Answers are grounded in this paper and cite their sources.
During the process development of Macitentan (1), four related substance (impurities) were detected by high performance liquid chromatography (HPLC) in the final crude material ranging from 0.20 to 0.50% and these are identified by Liquid chromatography-mass spectrometry (LC–MS). All impurities were subsequently synthesized, characterized by spectroscopic techniques and further analyzed and confirmed by chromatographic techniques by spiking and purging study and this impurities are namely 2, 2'-{[5-(4-bromophenyl) pyrimidine-4,6-diyl]bis(oxy)}diethanol (8), 5-(4-bromo-phenyl)-4,6-bis-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]- pyrimidine (9), N-[5-(4-bromophenyl)-6-(2-{[5-(4-bromophenyl)-6-chloropyrimidin-4-yl]oxy}ethoxy)-4-pyrimidinyl] -N'-propylsulfamide (10) and 2-{[5-(4-bromophenyl)-6-{[(propylamino)sulfonyl]amino} pyrimidin-4-yl]oxy}ethylacetate (11).
No takes yet. Share an insight, caveat, or question.
Jagtap et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: